Annual Income Statements for Community Healthcare Trust
This table shows Community Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Community Healthcare Trust
This table shows Community Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Net Income / (Loss) Attributable to Common Shareholders |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Consolidated Net Income / (Loss) |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Net Income / (Loss) Continuing Operations |
|
5.67 |
5.22 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Total Pre-Tax Income |
|
5.69 |
2.63 |
-6.89 |
6.63 |
3.82 |
4.47 |
3.67 |
-10 |
1.74 |
1.84 |
Total Revenue |
|
22 |
22 |
23 |
24 |
24 |
24 |
24 |
28 |
30 |
11 |
Net Interest Income / (Expense) |
|
-3.02 |
-3.46 |
-3.97 |
-3.39 |
-4.64 |
-4.98 |
-5.06 |
0.31 |
0.21 |
-19 |
Total Interest Income |
|
0.01 |
0.00 |
0.03 |
0.75 |
0.00 |
0.04 |
0.00 |
0.31 |
0.21 |
0.02 |
Total Interest Expense |
|
3.03 |
3.46 |
3.99 |
4.14 |
4.64 |
5.02 |
5.06 |
0.00 |
0.00 |
19 |
Total Non-Interest Income |
|
25 |
25 |
27 |
28 |
29 |
29 |
29 |
28 |
30 |
29 |
Other Service Charges |
|
0.89 |
0.96 |
1.05 |
1.05 |
1.05 |
1.02 |
0.99 |
-0.39 |
0.30 |
0.32 |
Other Non-Interest Income |
|
24 |
24 |
26 |
27 |
28 |
28 |
28 |
28 |
29 |
29 |
Total Non-Interest Expense |
|
16 |
17 |
30 |
18 |
20 |
20 |
21 |
21 |
22 |
21 |
Property & Liability Insurance Claims |
|
4.33 |
4.16 |
4.87 |
4.79 |
5.46 |
5.60 |
5.79 |
5.57 |
5.99 |
5.49 |
Other Operating Expenses |
|
3.76 |
4.15 |
16 |
3.79 |
3.62 |
3.73 |
4.55 |
4.76 |
4.94 |
4.81 |
Depreciation Expense |
|
8.00 |
8.32 |
9.02 |
9.22 |
11 |
10 |
10 |
11 |
11 |
11 |
Basic Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Weighted Average Basic Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Diluted Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Weighted Average Diluted Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Weighted Average Basic & Diluted Shares Outstanding |
|
25.30M |
26.02M |
26.30M |
26.56M |
27.26M |
27.68M |
27.70M |
28.06M |
28.24M |
28.34M |
Annual Cash Flow Statements for Community Healthcare Trust
This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
9.20 |
-7.44 |
-0.25 |
Net Cash From Operating Activities |
60 |
61 |
59 |
Net Cash From Continuing Operating Activities |
60 |
61 |
59 |
Net Income / (Loss) Continuing Operations |
22 |
7.71 |
-3.18 |
Consolidated Net Income / (Loss) |
22 |
7.71 |
-3.18 |
Provision For Loan Losses |
0.00 |
0.00 |
11 |
Depreciation Expense |
32 |
40 |
43 |
Amortization Expense |
0.85 |
13 |
0.93 |
Non-Cash Adjustments to Reconcile Net Income |
6.01 |
4.82 |
8.17 |
Changes in Operating Assets and Liabilities, net |
-0.94 |
-3.39 |
-0.81 |
Net Cash From Investing Activities |
-114 |
-114 |
-93 |
Net Cash From Continuing Investing Activities |
-113 |
-114 |
-92 |
Purchase of Property, Leasehold Improvements and Equipment |
-10 |
-19 |
-25 |
Purchase of Investment Securities |
-106 |
-101 |
-75 |
Sale and/or Maturity of Investments |
3.00 |
6.19 |
7.42 |
Other Investing Activities, net |
0.67 |
- |
0.22 |
Net Cash From Financing Activities |
63 |
45 |
34 |
Net Cash From Continuing Financing Activities |
63 |
45 |
34 |
Issuance of Debt |
150 |
50 |
162 |
Issuance of Common Equity |
21 |
44 |
7.49 |
Repayment of Debt |
-63 |
-0.13 |
-83 |
Payment of Dividends |
-44 |
-48 |
-52 |
Other Financing Activities, Net |
-0.39 |
-1.19 |
-1.01 |
Cash Interest Paid |
11 |
18 |
23 |
Quarterly Cash Flow Statements for Community Healthcare Trust
This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Net Change in Cash & Equivalents |
|
0.98 |
8.73 |
-7.44 |
-0.95 |
1.26 |
-0.30 |
0.31 |
-4.21 |
2.10 |
1.55 |
Net Cash From Operating Activities |
|
15 |
15 |
13 |
17 |
18 |
14 |
13 |
17 |
14 |
16 |
Net Cash From Continuing Operating Activities |
|
15 |
15 |
13 |
17 |
18 |
14 |
13 |
17 |
14 |
16 |
Net Income / (Loss) Continuing Operations |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Consolidated Net Income / (Loss) |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Depreciation Expense |
|
8.00 |
8.32 |
9.02 |
9.22 |
11 |
10 |
10 |
11 |
11 |
11 |
Amortization Expense |
|
0.21 |
0.23 |
12 |
0.24 |
0.05 |
0.19 |
0.22 |
0.17 |
0.25 |
0.29 |
Non-Cash Adjustments to Reconcile Net Income |
|
1.63 |
1.81 |
1.67 |
0.22 |
1.78 |
1.16 |
1.67 |
2.81 |
1.81 |
1.87 |
Changes in Operating Assets and Liabilities, net |
|
-0.16 |
-0.18 |
-3.13 |
0.42 |
1.19 |
-1.87 |
-3.17 |
2.38 |
-0.90 |
0.87 |
Net Cash From Investing Activities |
|
-22 |
-58 |
-29 |
-16 |
-55 |
-14 |
-39 |
-30 |
-14 |
-9.49 |
Net Cash From Continuing Investing Activities |
|
-22 |
-57 |
-29 |
-16 |
-55 |
-14 |
-39 |
-30 |
-14 |
-9.43 |
Purchase of Property, Leasehold Improvements and Equipment |
|
-3.05 |
-3.68 |
-4.14 |
-3.75 |
-3.58 |
-7.52 |
-5.11 |
-7.19 |
-7.19 |
-5.16 |
Purchase of Investment Securities |
|
-20 |
-55 |
-25 |
-17 |
-52 |
-6.90 |
-34 |
-24 |
-8.91 |
-8.42 |
Sale and/or Maturity of Investments |
|
0.75 |
0.75 |
0.75 |
3.78 |
0.79 |
0.87 |
0.87 |
0.75 |
1.72 |
4.09 |
Other Investing Activities, net |
|
- |
- |
- |
- |
- |
- |
0.03 |
0.05 |
0.08 |
0.06 |
Net Cash From Financing Activities |
|
7.73 |
51 |
8.44 |
-1.15 |
39 |
-1.04 |
26 |
9.32 |
2.64 |
-4.63 |
Net Cash From Continuing Financing Activities |
|
7.73 |
51 |
8.44 |
-1.15 |
39 |
-1.04 |
26 |
9.32 |
2.64 |
-4.63 |
Issuance of Debt |
|
19 |
105 |
12 |
3.00 |
33 |
2.00 |
39 |
20 |
16 |
87 |
Repayment of Debt |
|
-0.03 |
-63 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-4.79 |
- |
-78 |
Payment of Dividends |
|
-11 |
-11 |
-12 |
-12 |
-12 |
-12 |
-13 |
-13 |
-13 |
-13 |
Other Financing Activities, Net |
|
-0.05 |
-0.21 |
-0.10 |
-1.01 |
-0.04 |
-0.05 |
-0.61 |
-0.06 |
-0.29 |
-0.05 |
Cash Interest Paid |
|
2.61 |
3.21 |
4.06 |
4.16 |
2.17 |
7.34 |
4.79 |
5.91 |
6.23 |
6.14 |
Annual Balance Sheets for Community Healthcare Trust
This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Total Assets |
876 |
945 |
993 |
Cash and Due from Banks |
11 |
3.49 |
4.38 |
Restricted Cash |
0.84 |
1.14 |
0.00 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
Premises and Equipment, Net |
778 |
849 |
903 |
Other Assets |
87 |
91 |
85 |
Total Liabilities & Shareholders' Equity |
876 |
945 |
993 |
Total Liabilities |
380 |
432 |
517 |
Other Short-Term Payables |
11 |
12 |
14 |
Long-Term Debt |
353 |
403 |
486 |
Other Long-Term Liabilities |
15 |
17 |
16 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
497 |
513 |
476 |
Total Preferred & Common Equity |
497 |
513 |
476 |
Preferred Stock |
0.00 |
0.00 |
0.00 |
Total Common Equity |
497 |
513 |
476 |
Common Stock |
625 |
688 |
705 |
Retained Earnings |
-151 |
-192 |
-246 |
Accumulated Other Comprehensive Income / (Loss) |
23 |
16 |
18 |
Quarterly Balance Sheets for Community Healthcare Trust
This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Total Assets |
|
812 |
886 |
900 |
955 |
983 |
983 |
982 |
Cash and Due from Banks |
|
2.66 |
3.67 |
2.63 |
3.89 |
3.81 |
0.73 |
2.84 |
Restricted Cash |
|
0.68 |
0.96 |
1.05 |
1.05 |
1.14 |
0.00 |
0.00 |
Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Premises and Equipment, Net |
|
730 |
797 |
805 |
852 |
880 |
899 |
903 |
Other Assets |
|
79 |
85 |
92 |
98 |
98 |
84 |
76 |
Total Liabilities & Shareholders' Equity |
|
812 |
886 |
900 |
955 |
983 |
983 |
982 |
Total Liabilities |
|
333 |
392 |
395 |
433 |
471 |
485 |
505 |
Other Short-Term Payables |
|
8.14 |
10 |
11 |
15 |
12 |
12 |
14 |
Long-Term Debt |
|
311 |
365 |
368 |
401 |
442 |
458 |
474 |
Other Long-Term Liabilities |
|
15 |
16 |
16 |
16 |
17 |
16 |
16 |
Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
Total Preferred & Common Equity |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
Preferred Stock |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Common Equity |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
Common Stock |
|
602 |
649 |
657 |
677 |
691 |
700 |
702 |
Retained Earnings |
|
-145 |
-170 |
-175 |
-184 |
-201 |
-224 |
-235 |
Accumulated Other Comprehensive Income / (Loss) |
|
21 |
16 |
23 |
29 |
21 |
21 |
10 |
Annual Metrics And Ratios for Community Healthcare Trust
This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.
Metric |
2022 |
2023 |
2024 |
Growth Metrics |
- |
- |
- |
Revenue Growth |
7.21% |
11.64% |
-3.40% |
EBITDA Growth |
2.99% |
9.06% |
-32.75% |
EBIT Growth |
-1.61% |
-63.64% |
-139.66% |
NOPAT Growth |
-1.80% |
-64.97% |
-128.87% |
Net Income Growth |
-2.10% |
-64.97% |
-141.24% |
EPS Growth |
-6.90% |
-75.31% |
-215.00% |
Operating Cash Flow Growth |
6.98% |
1.83% |
-4.08% |
Free Cash Flow Firm Growth |
-58.75% |
41.05% |
19.25% |
Invested Capital Growth |
16.77% |
7.85% |
4.95% |
Revenue Q/Q Growth |
1.69% |
2.41% |
-12.70% |
EBITDA Q/Q Growth |
-0.31% |
1.86% |
-25.01% |
EBIT Q/Q Growth |
-2.99% |
-9.01% |
-113.96% |
NOPAT Q/Q Growth |
9.37% |
24.64% |
-605.32% |
Net Income Q/Q Growth |
-3.82% |
-8.00% |
-613.23% |
EPS Q/Q Growth |
-6.90% |
-4.76% |
-130.00% |
Operating Cash Flow Q/Q Growth |
0.69% |
-1.79% |
2.39% |
Free Cash Flow Firm Q/Q Growth |
-100.50% |
53.93% |
-71.98% |
Invested Capital Q/Q Growth |
7.67% |
-0.76% |
1.16% |
Profitability Metrics |
- |
- |
- |
EBITDA Margin |
64.34% |
62.86% |
43.76% |
EBIT Margin |
25.69% |
8.37% |
-3.43% |
Profit (Net Income) Margin |
25.64% |
8.05% |
-3.43% |
Tax Burden Percent |
99.81% |
96.18% |
100.00% |
Interest Burden Percent |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
0.19% |
3.82% |
0.00% |
Return on Invested Capital (ROIC) |
2.79% |
0.87% |
-0.24% |
ROIC Less NNEP Spread (ROIC-NNEP) |
2.79% |
0.87% |
-0.45% |
Return on Net Nonoperating Assets (RNNOA) |
1.80% |
0.65% |
-0.41% |
Return on Equity (ROE) |
4.59% |
1.53% |
-0.64% |
Cash Return on Invested Capital (CROIC) |
-12.68% |
-6.68% |
-5.07% |
Operating Return on Assets (OROA) |
2.71% |
0.88% |
-0.33% |
Return on Assets (ROA) |
2.70% |
0.85% |
-0.33% |
Return on Common Equity (ROCE) |
4.59% |
1.53% |
-0.64% |
Return on Equity Simple (ROE_SIMPLE) |
4.43% |
1.50% |
-0.67% |
Net Operating Profit after Tax (NOPAT) |
22 |
7.71 |
-2.23 |
NOPAT Margin |
25.64% |
8.05% |
-2.40% |
Net Nonoperating Expense Percent (NNEP) |
0.00% |
0.00% |
0.21% |
SG&A Expenses to Revenue |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
74.31% |
91.63% |
91.56% |
Earnings before Interest and Taxes (EBIT) |
22 |
8.02 |
-3.18 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
55 |
60 |
41 |
Valuation Ratios |
- |
- |
- |
Price to Book Value (P/BV) |
1.59 |
1.30 |
1.14 |
Price to Tangible Book Value (P/TBV) |
1.59 |
1.30 |
1.14 |
Price to Revenue (P/Rev) |
9.18 |
6.96 |
5.86 |
Price to Earnings (P/E) |
35.82 |
86.48 |
0.00 |
Dividend Yield |
5.66% |
7.38% |
9.60% |
Earnings Yield |
2.79% |
1.16% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
1.33 |
1.16 |
1.06 |
Enterprise Value to Revenue (EV/Rev) |
13.15 |
11.12 |
11.06 |
Enterprise Value to EBITDA (EV/EBITDA) |
20.44 |
17.69 |
25.27 |
Enterprise Value to EBIT (EV/EBIT) |
51.20 |
132.88 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
51.30 |
138.15 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
18.74 |
17.36 |
17.39 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
- |
- |
- |
Debt to Equity |
0.71 |
0.79 |
1.02 |
Long-Term Debt to Equity |
0.71 |
0.79 |
1.02 |
Financial Leverage |
0.65 |
0.75 |
0.90 |
Leverage Ratio |
1.70 |
1.80 |
1.96 |
Compound Leverage Factor |
1.70 |
1.80 |
1.96 |
Debt to Total Capital |
41.54% |
44.00% |
50.52% |
Short-Term Debt to Total Capital |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
41.54% |
44.00% |
50.52% |
Preferred Equity to Total Capital |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
58.46% |
56.00% |
49.48% |
Debt to EBITDA |
6.39 |
6.69 |
11.99 |
Net Debt to EBITDA |
6.17 |
6.62 |
11.88 |
Long-Term Debt to EBITDA |
6.39 |
6.69 |
11.99 |
Debt to NOPAT |
16.03 |
52.28 |
-218.24 |
Net Debt to NOPAT |
15.48 |
51.68 |
-216.27 |
Long-Term Debt to NOPAT |
16.03 |
52.28 |
-218.24 |
Noncontrolling Interest Sharing Ratio |
0.00% |
0.00% |
0.00% |
Liquidity Ratios |
- |
- |
- |
Cash Flow Metrics |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
-100 |
-59 |
-48 |
Operating Cash Flow to CapEx |
580.96% |
323.39% |
238.93% |
Free Cash Flow to Firm to Interest Expense |
-8.43 |
-3.32 |
-2.01 |
Operating Cash Flow to Interest Expense |
5.08 |
3.45 |
2.48 |
Operating Cash Flow Less CapEx to Interest Expense |
4.20 |
2.38 |
1.44 |
Efficiency Ratios |
- |
- |
- |
Asset Turnover |
0.11 |
0.11 |
0.10 |
Fixed Asset Turnover |
0.12 |
0.12 |
0.11 |
Capital & Investment Metrics |
- |
- |
- |
Invested Capital |
850 |
917 |
962 |
Invested Capital Turnover |
0.11 |
0.11 |
0.10 |
Increase / (Decrease) in Invested Capital |
122 |
67 |
45 |
Enterprise Value (EV) |
1,130 |
1,066 |
1,024 |
Market Capitalization |
789 |
667 |
543 |
Book Value per Share |
$19.64 |
$18.83 |
$16.85 |
Tangible Book Value per Share |
$19.64 |
$18.83 |
$16.85 |
Total Capital |
850 |
917 |
962 |
Total Debt |
353 |
403 |
486 |
Total Long-Term Debt |
353 |
403 |
486 |
Net Debt |
341 |
399 |
482 |
Capital Expenditures (CapEx) |
10 |
19 |
25 |
Net Nonoperating Expense (NNE) |
0.00 |
0.00 |
0.95 |
Net Nonoperating Obligations (NNO) |
353 |
403 |
486 |
Total Depreciation and Amortization (D&A) |
33 |
52 |
44 |
Earnings Adjustments |
- |
- |
- |
Adjusted Basic Earnings per Share |
$0.81 |
$0.20 |
($0.23) |
Adjusted Weighted Average Basic Shares Outstanding |
23.63M |
25.20M |
26.53M |
Adjusted Diluted Earnings per Share |
$0.81 |
$0.20 |
($0.23) |
Adjusted Weighted Average Diluted Shares Outstanding |
23.63M |
25.20M |
26.53M |
Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
26.02M |
27.68M |
28.34M |
Normalized Net Operating Profit after Tax (NOPAT) |
22 |
7.81 |
-2.14 |
Normalized NOPAT Margin |
25.64% |
8.15% |
-2.31% |
Pre Tax Income Margin |
25.69% |
8.37% |
-3.43% |
Debt Service Ratios |
- |
- |
- |
EBIT to Interest Expense |
1.86 |
0.45 |
-0.13 |
NOPAT to Interest Expense |
1.85 |
0.43 |
-0.09 |
EBIT Less CapEx to Interest Expense |
0.98 |
-0.62 |
-1.17 |
NOPAT Less CapEx to Interest Expense |
0.98 |
-0.63 |
-1.13 |
Payout Ratios |
- |
- |
- |
Dividend Payout Ratio |
202.03% |
623.01% |
-1,625.21% |
Augmented Payout Ratio |
202.03% |
623.01% |
-1,625.21% |
Quarterly Metrics And Ratios for Community Healthcare Trust
This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Revenue Growth |
|
6.44% |
6.98% |
11.28% |
14.38% |
10.61% |
10.33% |
4.58% |
13.94% |
23.85% |
-55.80% |
EBITDA Growth |
|
3.67% |
-1.22% |
3.88% |
15.92% |
8.40% |
7.96% |
-0.36% |
-59.49% |
27.22% |
-95.40% |
EBIT Growth |
|
5.46% |
-11.45% |
-225.06% |
18.34% |
-33.00% |
-15.10% |
153.22% |
-167.01% |
109.62% |
-332.97% |
NOPAT Growth |
|
-30.31% |
272.56% |
-159.16% |
17.45% |
-36.65% |
69.51% |
176.02% |
-147.27% |
122.51% |
-58.86% |
Net Income Growth |
|
5.96% |
-14.31% |
-225.31% |
17.78% |
-38.45% |
-12.81% |
152.95% |
-258.54% |
-49.91% |
-59.89% |
EPS Growth |
|
5.00% |
-25.00% |
-252.38% |
14.29% |
-47.62% |
-5.56% |
134.38% |
-275.00% |
-63.64% |
-76.47% |
Operating Cash Flow Growth |
|
15.85% |
2.77% |
-11.83% |
10.31% |
15.41% |
-7.26% |
-0.43% |
0.32% |
-21.85% |
9.60% |
Free Cash Flow Firm Growth |
|
47.30% |
-40.95% |
-459.26% |
-134.76% |
-102.95% |
47.89% |
26.61% |
16.77% |
85.16% |
29.99% |
Invested Capital Growth |
|
9.74% |
16.77% |
16.04% |
14.22% |
17.01% |
7.85% |
10.98% |
9.38% |
2.97% |
4.95% |
Revenue Q/Q Growth |
|
2.05% |
0.44% |
6.07% |
5.21% |
-1.32% |
0.18% |
0.54% |
14.63% |
7.27% |
-64.25% |
EBITDA Q/Q Growth |
|
0.18% |
-0.74% |
2.85% |
13.34% |
-6.31% |
-1.14% |
-6.36% |
-53.92% |
194.20% |
-96.42% |
EBIT Q/Q Growth |
|
1.68% |
-7.64% |
-230.96% |
196.22% |
-42.43% |
17.04% |
-21.50% |
-221.17% |
280.07% |
-230.07% |
NOPAT Q/Q Growth |
|
1.30% |
-53.57% |
-283.03% |
236.43% |
-45.36% |
24.23% |
-21.50% |
-184.82% |
357.25% |
-77.03% |
Net Income Q/Q Growth |
|
1.59% |
-7.67% |
-232.15% |
195.02% |
-46.91% |
30.78% |
-19.75% |
-384.50% |
116.77% |
4.75% |
EPS Q/Q Growth |
|
0.00% |
-14.29% |
-277.78% |
175.00% |
-54.17% |
54.55% |
-35.29% |
-481.82% |
109.52% |
0.00% |
Operating Cash Flow Q/Q Growth |
|
1.55% |
0.38% |
-17.60% |
31.33% |
6.24% |
-19.33% |
-11.54% |
32.32% |
-17.24% |
13.14% |
Free Cash Flow Firm Q/Q Growth |
|
-47.86% |
-85.57% |
-3.49% |
17.33% |
-27.83% |
52.36% |
-46.26% |
6.25% |
77.21% |
-124.77% |
Invested Capital Q/Q Growth |
|
3.21% |
7.67% |
1.15% |
1.61% |
5.73% |
-0.76% |
4.09% |
0.15% |
-0.47% |
1.16% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBITDA Margin |
|
63.83% |
63.08% |
61.16% |
65.89% |
62.55% |
61.72% |
58.27% |
23.43% |
64.25% |
6.43% |
EBIT Margin |
|
26.14% |
24.03% |
-29.67% |
27.14% |
15.83% |
18.50% |
15.10% |
-15.96% |
26.80% |
-97.49% |
Profit (Net Income) Margin |
|
26.04% |
23.94% |
-29.82% |
26.93% |
14.49% |
18.92% |
15.10% |
-37.48% |
5.86% |
17.17% |
Tax Burden Percent |
|
99.63% |
198.86% |
100.51% |
99.25% |
91.53% |
102.28% |
100.00% |
100.00% |
100.29% |
99.73% |
Interest Burden Percent |
|
100.00% |
50.09% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
234.79% |
21.81% |
-17.66% |
Effective Tax Rate |
|
0.37% |
0.00% |
0.00% |
0.75% |
5.79% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
2.92% |
1.31% |
-2.29% |
3.00% |
1.63% |
2.01% |
1.61% |
-1.23% |
3.03% |
1.70% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
2.92% |
2.15% |
-2.95% |
3.00% |
1.60% |
2.03% |
1.61% |
-3.00% |
1.60% |
1.70% |
Return on Net Nonoperating Assets (RNNOA) |
|
1.76% |
1.39% |
-1.94% |
2.02% |
1.14% |
1.52% |
1.30% |
-2.47% |
1.40% |
1.53% |
Return on Equity (ROE) |
|
4.68% |
2.70% |
-4.23% |
5.03% |
2.77% |
3.53% |
2.91% |
-3.69% |
4.44% |
3.22% |
Cash Return on Invested Capital (CROIC) |
|
-6.62% |
-12.68% |
-13.97% |
-12.29% |
-14.95% |
-6.68% |
-8.38% |
-8.78% |
-2.96% |
-5.07% |
Operating Return on Assets (OROA) |
|
2.83% |
2.53% |
-3.18% |
2.94% |
1.68% |
1.95% |
1.57% |
-1.70% |
2.94% |
-9.32% |
Return on Assets (ROA) |
|
2.82% |
2.52% |
-3.19% |
2.92% |
1.54% |
1.99% |
1.57% |
-3.99% |
0.64% |
1.64% |
Return on Common Equity (ROCE) |
|
4.68% |
2.70% |
-4.23% |
5.03% |
2.77% |
3.53% |
2.91% |
-3.69% |
4.44% |
3.22% |
Return on Equity Simple (ROE_SIMPLE) |
|
4.78% |
0.00% |
1.94% |
2.09% |
1.61% |
0.00% |
3.58% |
0.26% |
-0.09% |
0.00% |
Net Operating Profit after Tax (NOPAT) |
|
5.67 |
2.63 |
-4.82 |
6.58 |
3.59 |
4.47 |
3.67 |
-3.11 |
8.00 |
1.84 |
NOPAT Margin |
|
26.04% |
12.04% |
-20.77% |
26.93% |
14.91% |
18.50% |
15.10% |
-11.17% |
26.80% |
17.22% |
Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
-0.84% |
0.66% |
0.00% |
0.03% |
-0.03% |
0.00% |
1.77% |
1.43% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
73.86% |
75.97% |
129.67% |
72.86% |
84.17% |
81.50% |
84.90% |
76.43% |
73.20% |
197.49% |
Earnings before Interest and Taxes (EBIT) |
|
5.69 |
5.26 |
-6.89 |
6.63 |
3.82 |
4.47 |
3.67 |
-4.44 |
8.00 |
-10 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
14 |
14 |
14 |
16 |
15 |
15 |
14 |
6.52 |
19 |
0.69 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
1.51 |
1.59 |
1.74 |
1.57 |
1.40 |
1.30 |
1.35 |
1.27 |
1.07 |
1.14 |
Price to Tangible Book Value (P/TBV) |
|
1.51 |
1.59 |
1.74 |
1.57 |
1.40 |
1.30 |
1.35 |
1.27 |
1.07 |
1.14 |
Price to Revenue (P/Rev) |
|
8.58 |
9.18 |
9.74 |
8.69 |
7.80 |
6.96 |
7.15 |
6.30 |
4.80 |
5.86 |
Price to Earnings (P/E) |
|
31.64 |
35.82 |
89.79 |
75.12 |
87.07 |
86.48 |
37.65 |
451.84 |
0.00 |
0.00 |
Dividend Yield |
|
6.08% |
5.66% |
5.37% |
5.92% |
6.53% |
7.38% |
7.14% |
8.00% |
10.11% |
9.60% |
Earnings Yield |
|
3.16% |
2.79% |
1.11% |
1.33% |
1.15% |
1.16% |
2.66% |
0.22% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
|
1.31 |
1.33 |
1.42 |
1.33 |
1.22 |
1.16 |
1.18 |
1.14 |
1.03 |
1.06 |
Enterprise Value to Revenue (EV/Rev) |
|
12.22 |
13.15 |
13.83 |
12.69 |
12.03 |
11.12 |
11.66 |
10.85 |
9.24 |
11.06 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
18.62 |
20.44 |
21.87 |
19.97 |
19.04 |
17.69 |
23.30 |
21.81 |
18.14 |
25.27 |
Enterprise Value to EBIT (EV/EBIT) |
|
45.38 |
51.20 |
126.21 |
108.31 |
127.79 |
132.88 |
60.53 |
58.53 |
43.01 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
51.25 |
51.30 |
173.27 |
143.55 |
182.00 |
138.15 |
61.42 |
672.23 |
0.00 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
17.24 |
18.74 |
20.83 |
19.26 |
18.02 |
17.36 |
18.43 |
17.74 |
17.04 |
17.39 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Debt to Equity |
|
0.65 |
0.71 |
0.74 |
0.73 |
0.77 |
0.79 |
0.86 |
0.92 |
0.99 |
1.02 |
Long-Term Debt to Equity |
|
0.65 |
0.71 |
0.74 |
0.73 |
0.77 |
0.79 |
0.86 |
0.92 |
0.99 |
1.02 |
Financial Leverage |
|
0.60 |
0.65 |
0.66 |
0.67 |
0.71 |
0.75 |
0.80 |
0.82 |
0.88 |
0.90 |
Leverage Ratio |
|
1.66 |
1.70 |
1.71 |
1.72 |
1.77 |
1.80 |
1.86 |
1.88 |
1.94 |
1.96 |
Compound Leverage Factor |
|
1.66 |
0.85 |
1.71 |
1.72 |
1.77 |
1.80 |
1.86 |
4.41 |
0.42 |
-0.35 |
Debt to Total Capital |
|
39.38% |
41.54% |
42.47% |
42.15% |
43.44% |
44.00% |
46.37% |
47.90% |
49.82% |
50.52% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
39.38% |
41.54% |
42.47% |
42.15% |
43.44% |
44.00% |
46.37% |
47.90% |
49.82% |
50.52% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
60.62% |
58.46% |
57.53% |
57.85% |
56.56% |
56.00% |
53.63% |
52.10% |
50.18% |
49.48% |
Debt to EBITDA |
|
5.61 |
6.39 |
6.54 |
6.35 |
6.78 |
6.69 |
9.12 |
9.16 |
8.77 |
11.99 |
Net Debt to EBITDA |
|
5.55 |
6.17 |
6.46 |
6.28 |
6.70 |
6.62 |
9.02 |
9.15 |
8.71 |
11.88 |
Long-Term Debt to EBITDA |
|
5.61 |
6.39 |
6.54 |
6.35 |
6.78 |
6.69 |
9.12 |
9.16 |
8.77 |
11.99 |
Debt to NOPAT |
|
15.44 |
16.03 |
51.85 |
45.63 |
64.82 |
52.28 |
24.04 |
282.48 |
-1,500.53 |
-218.24 |
Net Debt to NOPAT |
|
15.27 |
15.48 |
51.19 |
45.17 |
64.03 |
51.68 |
23.77 |
282.03 |
-1,491.54 |
-216.27 |
Long-Term Debt to NOPAT |
|
15.44 |
16.03 |
51.85 |
45.63 |
64.82 |
52.28 |
24.04 |
282.48 |
-1,500.53 |
-218.24 |
Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
-64 |
-119 |
-124 |
-102 |
-131 |
-62 |
-91 |
-85 |
-19 |
-44 |
Operating Cash Flow to CapEx |
|
503.31% |
418.98% |
306.86% |
445.17% |
495.30% |
190.05% |
247.27% |
232.83% |
192.69% |
303.51% |
Free Cash Flow to Firm to Interest Expense |
|
-21.26 |
-34.48 |
-30.97 |
-24.68 |
-28.15 |
-12.40 |
-17.92 |
0.00 |
0.00 |
-2.34 |
Operating Cash Flow to Interest Expense |
|
5.07 |
4.45 |
3.18 |
4.03 |
3.82 |
2.85 |
2.50 |
0.00 |
0.00 |
0.84 |
Operating Cash Flow Less CapEx to Interest Expense |
|
4.06 |
3.39 |
2.14 |
3.12 |
3.05 |
1.35 |
1.49 |
0.00 |
0.00 |
0.56 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Asset Turnover |
|
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.10 |
0.11 |
0.11 |
0.10 |
Fixed Asset Turnover |
|
0.08 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.11 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Invested Capital |
|
789 |
850 |
860 |
873 |
923 |
917 |
954 |
955 |
951 |
962 |
Invested Capital Turnover |
|
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.10 |
Increase / (Decrease) in Invested Capital |
|
70 |
122 |
119 |
109 |
134 |
67 |
94 |
82 |
27 |
45 |
Enterprise Value (EV) |
|
1,032 |
1,130 |
1,220 |
1,158 |
1,126 |
1,066 |
1,130 |
1,089 |
980 |
1,024 |
Market Capitalization |
|
724 |
789 |
860 |
794 |
730 |
667 |
693 |
632 |
509 |
543 |
Book Value per Share |
|
$19.06 |
$19.64 |
$19.00 |
$19.21 |
$19.67 |
$18.83 |
$19.46 |
$17.97 |
$17.01 |
$16.85 |
Tangible Book Value per Share |
|
$19.06 |
$19.64 |
$19.00 |
$19.21 |
$19.67 |
$18.83 |
$19.46 |
$17.97 |
$17.01 |
$16.85 |
Total Capital |
|
789 |
850 |
860 |
873 |
923 |
917 |
954 |
955 |
951 |
962 |
Total Debt |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
Total Long-Term Debt |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
Net Debt |
|
307 |
341 |
360 |
364 |
396 |
399 |
437 |
457 |
471 |
482 |
Capital Expenditures (CapEx) |
|
3.05 |
3.68 |
4.14 |
3.75 |
3.58 |
7.52 |
5.11 |
7.19 |
7.19 |
5.16 |
Net Nonoperating Expense (NNE) |
|
0.00 |
-2.60 |
2.10 |
0.00 |
0.10 |
-0.10 |
0.00 |
7.32 |
6.25 |
0.01 |
Net Nonoperating Obligations (NNO) |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
Total Depreciation and Amortization (D&A) |
|
8.21 |
8.54 |
21 |
9.46 |
11 |
10 |
10 |
11 |
11 |
11 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Adjusted Weighted Average Basic Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Adjusted Diluted Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
25.30M |
26.02M |
26.30M |
26.56M |
27.26M |
27.68M |
27.70M |
28.06M |
28.24M |
28.34M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
5.67 |
1.84 |
-4.82 |
6.58 |
3.59 |
3.13 |
2.57 |
-3.01 |
5.60 |
1.29 |
Normalized NOPAT Margin |
|
26.04% |
8.43% |
-20.77% |
26.93% |
14.91% |
12.95% |
10.57% |
-10.82% |
18.76% |
12.05% |
Pre Tax Income Margin |
|
26.14% |
12.04% |
-29.67% |
27.14% |
15.83% |
18.50% |
15.10% |
-37.48% |
5.84% |
17.22% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
1.88 |
1.52 |
-1.73 |
1.60 |
0.82 |
0.89 |
0.72 |
0.00 |
0.00 |
-0.56 |
NOPAT to Interest Expense |
|
1.87 |
0.76 |
-1.21 |
1.59 |
0.77 |
0.89 |
0.72 |
0.00 |
0.00 |
0.10 |
EBIT Less CapEx to Interest Expense |
|
0.87 |
0.46 |
-2.76 |
0.70 |
0.05 |
-0.61 |
-0.29 |
0.00 |
0.00 |
-0.83 |
NOPAT Less CapEx to Interest Expense |
|
0.87 |
-0.30 |
-2.24 |
0.68 |
0.00 |
-0.61 |
-0.29 |
0.00 |
0.00 |
-0.18 |
Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
192.50% |
202.03% |
471.76% |
435.05% |
559.51% |
623.01% |
268.28% |
3,858.67% |
-11,430.72% |
-1,625.21% |
Augmented Payout Ratio |
|
192.50% |
202.03% |
471.76% |
435.05% |
559.51% |
623.01% |
268.28% |
3,858.67% |
-11,430.72% |
-1,625.21% |
Key Financial Trends
Community Healthcare Trust (NYSE: CHCT) has shown notable financial trends over the last four years, encompassing Q3 and Q4 of 2022 through Q4 2024. Below is an analysis of key financial metrics and observations:
- Consistent net income recovery: After experiencing net losses in early 2023 (notably Q1 and Q2 2023), CHCT has returned to profitability starting Q3 2023, sustained through 2024. Q4 2024 net income was positive at $1.83 million, indicating operational improvement.
- Increasing total revenues and non-interest income: Total revenue increased from roughly $21.88 million in Q4 2022 to $29.3 million+ in several 2024 quarters; non-interest income remains a strong contributor (~$27 million+ per quarter), supporting diversified income streams beyond interest.
- Strong operating cash flow generation: Net cash from operating activities stayed robust, ranging from ~$12.6 million in early 2023 quarters to $15.7 million in Q4 2024, supporting daily operations and investments.
- Steady investments in property and equipment: Capital expenditures (property, leasehold improvements) averaged between $5 million to over $7 million per quarter in 2024, reflecting ongoing investment in asset base.
- Dividend payments persist: Despite fluctuations in earnings, CHCT maintained and slightly increased dividend payments per share in 2024 quarters, currently around $0.46 per share quarterly, appealing to income-focused investors.
- Equity base remains solid: Total common equity stayed stable around $477 million in Q3 2024, supporting balance sheet strength.
- Net interest income volatility: Net interest income showed high variability, including a large negative swing in Q4 2024 (-$18.6 million) due to significantly high total interest expense ($18.6 million) compared to minimal interest income ($16,000), which could be linked to interest on debt or financing costs.
- Long-term debt fluctuations: The balance sheet reveals an increase in long-term debt from ~$365 million in Q1 2023 to $474 million by Q3 2024, showing that the company has been raising debt for financing purposes.
- Large interest expense impacting earnings: Interest expense steadily rose year-over-year, reaching $18.6 million in Q4 2024; this has materially pressured net interest income and overall profitability.
- Non-interest expenses high and rising: Non-interest expenses such as property & liability insurance claims, depreciation, and other operating expenses total about $21 million in Q4 2024, higher than prior periods, which compresses earnings margins.
Summary: Community Healthcare Trust has demonstrated resilience, recovering from negative earnings in early 2023 to steady profitability by late 2023 and through 2024. Strong cash flows and steady dividends reinforce operational stability. However, rising interest expenses and non-interest costs remain challenges, reflecting increased leverage and operational costs. Investors should watch how CHCT manages its interest expenses and continues to grow revenues while controlling costs.
09/18/25 02:47 PM ETAI Generated. May Contain Errors.